About 9 results found for searched term "84-82-2" (0.179 seconds)
Cat.No. | Name | Target |
---|---|---|
M7879 | Toxoflavin (Xanthothricin) | Wnt/beta-catenin |
PKF-118-310 | ||
Toxoflavin (Xanthothricin) is an antagonist of transcription factor 4 (TCF4)/β-catenin complex, also acts as an inhibitor of KDM4A, with antitumor and antibiotic activity. | ||
M10245 | Pemafibrate | PPAR |
K-877; (R)-K 13675; CS-2768 | ||
Pemafibrate is a potent and highly specific PPARα agonist, with EC50s of 1 nM, 1.10 μM and 1.58 μM for h-PPARα, h-PPARγ and h-PPARδ, respectively. | ||
M14854 | PI3K/mTOR Inhibitor-2 | PI3K |
PI3K/mTOR Inhibitor-2 is a potent dual pan-PI3K/mTOR inhibitor with IC50s of 3.4/34/16/1 nM for PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ and 4.7 nM for mTOR. Antitumor activity. | ||
M20550 | KHS101 hydrochloride | Microtubule |
KHS101 is a small-molecule inhibitor of TACC3, which is a key component of centrosome-microtubule dynamic networks. | ||
M28807 | SHU 9119 acetate | Melanocortin Receptor |
SHU 9119 acetate is a potent human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partial MC5R agonist; with IC50 values of 0.23, 0.06, and 0.09 nM for human MC3R, MC4R and MC5R, respectively. | ||
M28948 | GSK2226649A | Others |
GSK2226649A (compound 2) is a novel activator of satellite cell proliferation and enhanced repair of damaged muscle. | ||
M43944 | Tivanisiran | TRP Channel |
Tivanisiran is an siRNA that silences TRPV1 mRNA and can be used in studies related to dry eye. | ||
M53121 | LH-RH (7-10) | LHRH/GnRH |
LH-RH (7-10) is a tetrapeptide, one of major degradation products of luteinising-hormone releasing hormone (LHRH) via pituitary and hypothalamus. | ||
M53868 | SHU 9119 | Melanocortin Receptor |
SHU 9119 is a potent human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partial MC5R agonist; with IC50 values of 0.23, 0.06, and 0.09 nM for human MC3R, MC4R and MC5R, respectively. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.